ExLibris header image
SFX Logo
Title: Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125)
Source:

Journal of Medicinal Chemistry [0022-2623] yr:2013


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Wu, X. "Indazoles as potential c-met inhibitors: Design, synthesis and molecular docking studies." European journal of medicinal chemistry 65 (2013): 112-118. Link to SFX for this item
2. Hou, Y. "Iodine(III)-Mediated [3 + 2] Cyclization for One-Pot Synthesis of Benzo[d]isoxazole-4,7-diols in Aqueous Medium." Journal of organic chemistry 78.17 (2013): 8386-8395. Link to Full Text for this item Link to SFX for this item
3. Yuanxiang, W. "Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agent." Journal of medicinal chemistry 54.7 (2011): 2127-2142. Link to Full Text for this item Link to SFX for this item
4. Liu, L. "Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)." Journal of medicinal chemistry 51.13: 3688-3691. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.